Is Recursion Pharmaceuticals, Inc. (RXRX) a Buy, Sell, or Hold?
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$3.35 USD
$0.01 (0.3%)
- Volume
- 8.28M
- Average Volume
- 19.03M
- Market Capitalization
- $1.5B
- P/E Ratio
- -2.79
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $7.18
- Year Low
- $2.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.47
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
41
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
75
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.33M
RXRX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
RXRX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Borgeson Blake | director | 2026-07-07 | S-Sale | 3.9625 | 2026-07-09 |
| Dar Zavain | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Li Dean Y | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Borgeson Blake | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| HERSHBERG ROBERT | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Michor Franziska | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Sun Elaine D | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Dar Zavain | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Li Dean Y | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Bumpus Namandje | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Bumpus Namandje | director | 2026-06-18 | S-Sale | 3.18 | 2026-06-22 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-06-15 | F-InKind | 3.15 | 2026-06-17 |
| Gibson Christopher | director | 2026-06-05 | C-Conversion | 0 | 2026-06-05 |
| Gibson Christopher | director | 2026-06-05 | C-Conversion | 0 | 2026-06-05 |
| Gibson Christopher | director | 2026-06-05 | S-Sale | 3.62 | 2026-06-05 |
| Khan Najat | director, officer: CEO and President | 2026-06-05 | S-Sale | 3.5806 | 2026-06-05 |
| Bumpus Namandje | director | 2026-06-03 | S-Sale | 3.54 | 2026-06-04 |
| Borgeson Blake | director | 2026-06-02 | S-Sale | 3.68 | 2026-06-04 |
| Gibson Christopher | director | 2026-05-22 | C-Conversion | 0 | 2026-05-27 |
| Gibson Christopher | director | 2026-05-22 | C-Conversion | 0 | 2026-05-27 |
| Gibson Christopher | director | 2026-05-22 | S-Sale | 3.08 | 2026-05-27 |
| Hallett David | officer: Chief Scientific Officer | 2026-05-15 | F-InKind | 3.04 | 2026-05-19 |
| Khan Najat | director, officer: CEO and President | 2026-05-15 | F-InKind | 3.04 | 2026-05-19 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-05-15 | F-InKind | 3.04 | 2026-05-19 |
| Gibson Christopher | director | 2026-05-15 | F-InKind | 3.04 | 2026-05-19 |
| Gibson Christopher | director | 2026-05-07 | C-Conversion | 0 | 2026-05-08 |
| Gibson Christopher | director | 2026-05-07 | C-Conversion | 0 | 2026-05-08 |
| Gibson Christopher | director | 2026-05-07 | S-Sale | 3.37 | 2026-05-08 |
| Gibson Christopher | director | 2026-05-07 | G-Gift | 0 | 2026-05-08 |
| Borgeson Blake | director | 2026-05-05 | S-Sale | 3.52 | 2026-05-07 |
| Gibson Christopher | director | 2026-04-22 | C-Conversion | 0 | 2026-04-24 |
| Gibson Christopher | director | 2026-04-22 | C-Conversion | 0 | 2026-04-24 |
| Gibson Christopher | director | 2026-04-22 | S-Sale | 3.61 | 2026-04-24 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-04-06 | F-InKind | 3.11 | 2026-04-08 |
| Gibson Christopher | director | 2026-04-07 | C-Conversion | 0 | 2026-04-08 |
| Gibson Christopher | director | 2026-04-07 | C-Conversion | 0 | 2026-04-08 |
| Gibson Christopher | director | 2026-04-07 | S-Sale | 3.1 | 2026-04-08 |
| Borgeson Blake | director | 2026-04-07 | S-Sale | 3.1 | 2026-04-08 |
| Dar Zavain | director | 2026-04-01 | A-Award | 0 | 2026-04-02 |
| Li Dean Y | director | 2026-04-01 | A-Award | 0 | 2026-04-02 |
| Gibson Christopher | director | 2026-03-23 | C-Conversion | 0 | 2026-03-25 |
| Gibson Christopher | director | 2026-03-23 | C-Conversion | 0 | 2026-03-25 |
| Gibson Christopher | director | 2026-03-23 | S-Sale | 3.25 | 2026-03-25 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-03-16 | F-InKind | 3.42 | 2026-03-18 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-03-17 | S-Sale | 3.39 | 2026-03-18 |
| Gibson Christopher | director | 2026-03-09 | C-Conversion | 0 | 2026-03-11 |
| Gibson Christopher | director | 2026-03-09 | C-Conversion | 0 | 2026-03-11 |
| Gibson Christopher | director | 2026-03-09 | G-Gift | 0 | 2026-03-11 |
| Khan Najat | director, officer: CEO and President | 2026-03-09 | S-Sale | 3.3451 | 2026-03-11 |
| Borgeson Blake | director | 2026-03-03 | S-Sale | 3.46 | 2026-03-04 |
| Hallett David | officer: Chief Scientific Officer | 2026-02-17 | F-InKind | 3.49 | 2026-02-19 |
| Gibson Christopher | director | 2026-02-19 | C-Conversion | 0 | 2026-02-19 |
| Gibson Christopher | director | 2026-02-19 | C-Conversion | 0 | 2026-02-19 |
| Gibson Christopher | director | 2026-02-19 | S-Sale | 3.46 | 2026-02-19 |
| Gibson Christopher | director | 2026-02-17 | F-InKind | 3.49 | 2026-02-19 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-02-17 | F-InKind | 3.49 | 2026-02-19 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-02-18 | S-Sale | 3.08 | 2026-02-19 |
| Khan Najat | director, officer: CEO and President | 2026-02-17 | F-InKind | 3.49 | 2026-02-19 |
| Khan Najat | director, officer: CEO and President | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Khan Najat | director, officer: CEO and President | 2026-02-06 | F-InKind | 3.98 | 2026-02-10 |
| Khan Najat | director, officer: CEO and President | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-02-06 | F-InKind | 3.98 | 2026-02-10 |
| Taylor Ben R | officer: Chief Financial Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Hallett David | officer: Chief Scientific Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Hallett David | officer: Chief Scientific Officer | 2026-02-06 | F-InKind | 3.98 | 2026-02-10 |
| Hallett David | officer: Chief Scientific Officer | 2026-02-06 | A-Award | 0 | 2026-02-10 |
| Gibson Christopher | director | 2026-02-04 | C-Conversion | 0 | 2026-02-06 |
| Gibson Christopher | director | 2026-02-04 | C-Conversion | 0 | 2026-02-06 |
| Gibson Christopher | director | 2026-02-06 | A-Award | 0 | 2026-02-06 |
| Gibson Christopher | director | 2026-02-06 | F-InKind | 3.56 | 2026-02-06 |
| Gibson Christopher | director | 2026-02-04 | S-Sale | 4.12 | 2026-02-06 |
| Borgeson Blake | director | 2026-02-03 | S-Sale | 4.2 | 2026-02-06 |
| Gibson Christopher | director | 2026-01-20 | C-Conversion | 0 | 2026-01-22 |
| Gibson Christopher | director | 2026-01-20 | C-Conversion | 0 | 2026-01-22 |
| Gibson Christopher | director | 2026-01-20 | S-Sale | 4.47 | 2026-01-22 |
| Hallett David | officer: CSO | 2026-01-01 | 0 | 2026-01-09 | |
| Hallett David | officer: CSO | 2026-01-01 | 0 | 2026-01-09 | |
| Hallett David | officer: CSO | 2026-01-01 | 0 | 2026-01-09 | |
| Hallett David | officer: CSO | 2026-01-01 | 0.01 | 2026-01-09 | |
| Hallett David | officer: CSO | 2026-01-01 | 6.09 | 2026-01-09 | |
| Hallett David | officer: CSO | 2026-01-01 | 7.25 | 2026-01-09 | |
| Borgeson Blake | director | 2026-01-06 | S-Sale | 4.36 | 2026-01-08 |
| Gibson Christopher | director | 2026-01-05 | C-Conversion | 0 | 2026-01-07 |
| Gibson Christopher | director | 2026-01-05 | C-Conversion | 0 | 2026-01-07 |
| Gibson Christopher | director | 2026-01-05 | S-Sale | 4.25 | 2026-01-07 |
| Gibson Christopher | director | 2026-01-05 | G-Gift | 0 | 2026-01-07 |
| Dar Zavain | director | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Li Dean Y | director | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Taylor Ben R | officer: Chief Financial Officer | 2025-12-29 | S-Sale | 4.18 | 2025-12-30 |
| Khan Najat | director, officer: Chief R&D Commercial Officer | 2025-12-22 | S-Sale | 4.4098 | 2025-12-29 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-19 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-19 | C-Conversion | 0 | 2025-12-19 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-19 | S-Sale | 4.5 | 2025-12-19 |
| Taylor Ben R | officer: Chief Financial Officer | 2025-12-15 | F-InKind | 4.33 | 2025-12-17 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-04 | C-Conversion | 0 | 2025-12-05 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-04 | C-Conversion | 0 | 2025-12-05 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-04 | S-Sale | 4.63 | 2025-12-05 |
| Gibson Christopher | director, officer: Chief Executive Officer | 2025-12-04 | G-Gift | 0 | 2025-12-05 |
| Borgeson Blake | director | 2025-12-02 | S-Sale | 4.37 | 2025-12-04 |